Recent achievements and future developments in neonatal cardiopulmonary bypass

被引:10
|
作者
Bojan, Mirela [1 ]
机构
[1] Marie Lannelongue Hosp, Dept Anesthesiol, Congenital Cardiac Unit, 133 Ave Resistance, F-92350 Le Plessis Robinson, France
关键词
anticoagulation; blood products; cardiopulmonary bypass; congenital heart disease; hypothermia; monitoring devices; neonate; HYPOTHERMIC CIRCULATORY ARREST; NEAR-INFRARED SPECTROSCOPY; PEDIATRIC CARDIAC-SURGERY; BLOOD-CELL TRANSFUSION; PH-STAT STRATEGIES; AORTIC-ARCH REPAIR; CEREBRAL PERFUSION; NITRIC-OXIDE; POSTOPERATIVE MORBIDITY; CONTROLLED-TRIAL;
D O I
10.1111/pan.13597
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
A primary goal of improving neonatal cardiopulmonary bypass has been making the circuit smaller and reduce the blood contacting surfaces. As bypass circuit size has decreased, bloodless surgery has become possible even in neonates. Since transfusion guidelines are difficult to construct based on existing literature, these technical advances should be taken advantage of in conjunction with an individualized transfusion scheme, based on monitoring of oxygen availability to the tissues. For the majority of neonatal heart operations, several centers have shifted toward normothermic bypass even for complex neonatal surgeries, in order to avoid the adverse effects of hypothermia. Deep hypothermic circulatory arrest is no longer a necessity but an option, and selective antegrade cerebral perfusion has become common practice; however, technical uncertainties with regard to this technique have to be addressed, based on reliable neurologic monitoring. Maintenance of patient-specific heparin concentrations during bypass is another key goal, since neonates have lower baseline antithrombin concentrations and, therefore, a higher risk for inadequate thrombin inhibition and postoperative bleeding. Due to the immaturity of their hemostatic system, the standard coagulation tests alone are inappropriate to guide hemostatic therapy in neonates. The use of indirect heparin concentration assays and global viscoelastic assays in the operating room is likely to represent the optimal strategy, and requires validation in neonates. Monitoring of global and regional indexes of oxygen availability and consumption on bypass have become possible; however, their use in neonates still has outstanding technical issues which should be addressed and hence needs further validation. Due to the immaturity of the neonatal myocardium, single-shot cold cardioplegia solutions are thought to confer the best myocardial protection; their superiority when compared to more conventional modalities, however, remains to be demonstrated.
引用
收藏
页码:414 / 425
页数:12
相关论文
共 50 条
  • [31] NEONATAL JAUNDICE - RECENT DEVELOPMENTS - COMMENT
    GRAND, RJ
    WATKINS, JB
    KATZ, AJ
    LAWSON, EE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (19): : 1028 - 1028
  • [32] HTR-TN Achievements and Prospects for Future Developments
    Hittner, Dominique
    Angulo, Carmen
    Basini, Virginie
    Bogusch, Edgar
    Breuil, Eric
    Buckthorpe, Derek
    Chauvet, Vincent
    Futterer, Michael A.
    van Heek, Aliki
    von Lensa, Werner
    Verrier, Denis
    Yvon, Pascal
    [J]. JOURNAL OF ENGINEERING FOR GAS TURBINES AND POWER-TRANSACTIONS OF THE ASME, 2011, 133 (06):
  • [33] HTR-TN ACHIEVEMENTS AND PROSPECTS FOR FUTURE DEVELOPMENTS
    Hittner, Dominique
    Angulo, Carmen
    Basini, Virginie
    Bogusch, Edgar
    Breuil, Eric
    Buckthorpe, Derek
    Chauvet, Vincent
    Futterer, Michael A.
    van Heek, Aliki
    von Lensa, Werner
    Verrier, Denis
    Yvon, Pascal
    [J]. PROCEEDINGS OF THE 4TH INTERNATIONAL TOPICAL MEETING ON HIGH TEMPERATURE REACTOR TECHNOLOGY, VOL 1, 2009, : 99 - +
  • [34] Management of neonatal bronchovenous fistula after cardiopulmonary bypass
    Reinhartz, O
    DeSilva, AM
    Hanley, FL
    [J]. ANNALS OF THORACIC SURGERY, 2002, 73 (04): : 1320 - 1322
  • [35] Platelet accumulation after cardiopulmonary bypass in neonatal pigs
    Brix-Christensen, V
    Ravn, HB
    Hjortdal, VE
    Tonnesen, E
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 133 - 134
  • [36] Effects of cardiopulmonary bypass on neonatal and paediatric inflammatory profiles
    Ashraf, SS
    Tian, Y
    Zacharrias, S
    Cowan, D
    Martin, P
    Watterson, K
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 12 (06) : 862 - 868
  • [37] Neutrophil accumulation after cardiopulmonary bypass in neonatal pigs
    Brix-Christensen, V
    Hjortdal, VE
    Ravn, HB
    Tonnesen, E
    [J]. ANESTHESIOLOGY, 1999, 91 (3A) : U339 - U339
  • [38] Istanbul Symposium on Neonatal and Pediatric Cardiopulmonary Bypass Procedures
    Uendar, Akif
    Alkan-Bozkaya, Tijen
    Palanzo, David
    Ersayin-Kantas, Huriyet
    Chin, Chris
    Odemis, Ender
    Pekkan, Kerem
    Agirbasli, Mehmet A.
    Turkoz, Ayda
    Turkoz, Riza
    Haydin, Sertac
    Erek, Ersin
    Yalcinbas, Yusuf K.
    Sasmazel, Ahmet
    Karaci, Ali Riza
    Erkan, Halime
    Cicek, Ali Ekber
    Bakir, Ihsan
    Sarioglu, Tayyar
    Akcevin, Atif
    Aytac, Aydin
    [J]. ARTIFICIAL ORGANS, 2012, 36 (05) : 463 - 466
  • [39] Complement factor 1 inhibitor improves cardiopulmonary function in neonatal cardiopulmonary bypass
    Baig, Kamran
    Nassar, Rashid
    Craig, Damian M.
    Quick, George, Jr.
    Jiang, Hai Xiang
    Frank, Michael M.
    Lodge, Andrew J.
    Anderson, Page A. W.
    Jaggers, James
    [J]. ANNALS OF THORACIC SURGERY, 2007, 83 (04): : 1477 - 1483
  • [40] Perfluorocarbon emulsions and cardiopulmonary bypass: A technique for the future
    Spiess, BD
    Cochran, RP
    [J]. JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 1996, 10 (01) : 83 - 90